1.7987
前日終値:
$1.77
開ける:
$1.8
24時間の取引高:
22,008
Relative Volume:
2.51
時価総額:
$56.19M
収益:
-
当期純損益:
-
株価収益率:
-0.7139
EPS:
-2.5197
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.49%
1か月 パフォーマンス:
+6.43%
6か月 パフォーマンス:
-10.51%
1年 パフォーマンス:
-9.39%
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
ANL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ANL
Adlai Nortye Ltd Adr
|
1.7987 | 65.31M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-02 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2024-09-04 | 開始されました | H.C. Wainwright | Buy |
2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr (ANL) 最新ニュース
Chart based analysis of Adlai Nortye Ltd. Depositary Receipt trendsQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
Can technical indicators confirm LZ Technology Holdings Limited’s reversalMarket Weekly Review & AI Powered Market Entry Ideas - newser.com
How to monitor COHU with trend dashboards2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Can machine learning forecast Ubiquiti Inc. recoveryQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Top chart patterns to watch in ECARX Holdings Inc. Equity WarrantWeekly Trade Summary & Technical Pattern Based Signals - newser.com
Visual analytics tools that track Adlai Nortye Ltd. Depositary Receipt performanceMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Does PBHC show high probability of reboundJuly 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
Risk vs reward if holding onto Penns Woods Bancorp Inc.2025 Key Highlights & Smart Money Movement Alerts - newser.com
Is MSBI trending in predictive chart modelsQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Short Interest in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Declines By 65.7% - MarketBeat
Does Bentley Systems Incorporated qualify in momentum factor screening2025 Key Highlights & Consistent Return Investment Signals - newser.com
Earnings visualization tools for WSO.BJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com
Earnings visualization tools for DBRG.PRJQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Decrease in Short Interest - Defense World
Analysts Set Teradata Corporation (NYSE:TDC) PT at $26.86 - Defense World
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Increase in Short Interest - MarketBeat
What machine learning models say about Adlai Nortye Ltd. Depositary ReceiptTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Using portfolio simulators with Novo Nordisk A s (b Shares) Adrhedged includedJuly 2025 Selloffs & Trade Opportunity Analysis Reports - Newser
Live market analysis of SPAIJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - Newser
Key resistance and support levels for Adlai Nortye Ltd. Depositary ReceiptJuly 2025 Final Week & Fast Gain Stock Tips - Newser
Candlestick signals on FBGL stock todayForecast Cut & Stock Market Timing Techniques - Newser
F.N.B. Corporation stock trendline breakdownJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - Newser
Is Brookfield Asset Management Ltd. stock reversal real or fake2025 Price Action Summary & Reliable Price Breakout Alerts - Newser
How to use a screener to detect IROHW breakouts2025 Risk Factors & Expert Curated Trade Setups - Newser
Nuveen LLC Acquires Shares of 374,952 Theravance Biopharma, Inc. $TBPH - Defense World
Analyzing drawdowns of Coeptis Therapeutics Holdings Inc. with statistical toolsTrade Exit Summary & Real-Time Market Sentiment Reports - Newser
Is GSK plc ADRhedged forming a bottoming base2025 Biggest Moves & Precise Entry and Exit Recommendations - Newser
Trend analysis for Intercontinental Exchange Inc. this weekWeekly Risk Report & Reliable Intraday Trade Alerts - Newser
CoreWeave (NASDAQ:CRWV) Upgraded at Arete Research - Defense World
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Significant Increase in Short Interest - Defense World
Bank of Nova Scotia (The) (NYSE:BNS) Receives $81.00 Average Target Price from Brokerages - Defense World
Long term hold vs stop loss in CEADJuly 2025 PostEarnings & Reliable Price Breakout Alerts - Newser
Adlai Nortye (NASDAQ:ANL) Stock Price Up 3.2% – Should You Buy? - Defense World
Analysts Offer Insights on Healthcare Companies: Avalo Therapeutics (AVTX), Iovance Biotherapeutics (IOVA) and NextCure (NXTC) - The Globe and Mail
AlphaTime Acquisition Corp Debt Equity Composite Units recovery potential after sell offFree Long Hold Safe Return Strategy - Newser
Comparing Adlai Nortye Ltd. Depositary Receipt in custom built stock radarsDaily Upside Movement Prediction With Data - Newser
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Gilead Sciences (GILD) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail
Adlai Nortye Ltd. Announces 2025 Share Incentive Plan and Board Changes - TipRanks
Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail
Adlai Nortye (NASDAQ:ANL) Trading Down 5.5% – Here’s What Happened - Defense World
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Capricor Therapeutics (CAPR) and Abbott Laboratories (ABT) - The Globe and Mail
H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS By Investing.com - Investing.com South Africa
H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS - Investing.com
Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results - TipRanks
ANL stock touches 52-week low at $1.71 amid sharp annual decline - Investing.com India
ANL stock touches 52-week low at $1.71 amid sharp annual decline By Investing.com - Investing.com South Africa
Adlai Nortye to present at AACR Annual Meeting with two abstracts scheduled. - AInvest
ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa
ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com India
Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline By Investing.com - Investing.com South Africa
Adlai Nortye Ltd Adr (ANL) 財務データ
Adlai Nortye Ltd Adr (ANL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):